These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7695324)

  • 1. Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus.
    Lacassin F; Schaffo D; Perronne C; Longuet P; Leport C; Vilde JL
    Antimicrob Agents Chemother; 1995 Jan; 39(1):276-7. PubMed ID: 7695324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Maintenance treatment of cerebral toxoplasmosis in AIDS: role of clarithromycin-minocycline combination].
    Sellal A; Rabaud C; Amiel C; Hoen B; May T; Canton P
    Presse Med; 1996 Mar; 25(10):509. PubMed ID: 8685115
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J; Hutch T; Meulbroek JA; Clement JC
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antibiotic treatment with clarithromycin for human immunodeficiency virus-associated Rhodococcus equi infection.
    Pialoux G; Goldstein F; Dupont B; Gonzalez Canali G; Sansonetti P
    Clin Infect Dis; 1993 Sep; 17(3):513-4. PubMed ID: 8218702
    [No Abstract]   [Full Text] [Related]  

  • 5. A clarithromycin-induced myasthenic syndrome.
    Pijpers E; van Rijswijk RE; Takx-Köhlen B; Schrey G
    Clin Infect Dis; 1996 Jan; 22(1):175-6. PubMed ID: 8824993
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis.
    Derouin F; Caroff B; Chau F; Prokocimer P; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2852-5. PubMed ID: 1482160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S; Pudney M; Derouin F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
    Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF; Truffot C; Chauvin JP
    Rev Mal Respir; 1994; 11(3):271-6. PubMed ID: 8041990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
    Guelar A; Miró JM; Mallolas J; Zamora L; Cardenal C; Gatell JM; Soriano E
    Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):137-40. PubMed ID: 8011719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin].
    Esvant H; Legoupil I; Gaillat J; Bru JP
    Presse Med; 1993 May; 22(18):877. PubMed ID: 8337221
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV: opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
    [No Abstract]   [Full Text] [Related]  

  • 12. [Secondary prevention of opportunistic infections in HIV-infected patients].
    Asencio Marchante R; Lissen Otero E
    Rev Clin Esp; 2001 Feb; 201(2):88-9. PubMed ID: 11345612
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic approaches for AIDS-related toxoplasmosis.
    Behbahani R; Moshfeghi M; Baxter JD
    Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
    Roussel G; Igual J
    Int J Tuberc Lung Dis; 1998 Jun; 2(6):462-70. PubMed ID: 9626603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of toxoplasmosis in AIDS.
    Trikha I; Wig N
    Indian J Med Sci; 2001 Feb; 55(2):87-98. PubMed ID: 11482163
    [No Abstract]   [Full Text] [Related]  

  • 16. Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
    Araujo FG; Prokocimer P; Remington JS
    J Infect Dis; 1992 Apr; 165(4):788. PubMed ID: 1532409
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
    Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.
    Ji B; Jamet P; Perani EG; Bobin P; Grosset JH
    J Infect Dis; 1993 Jul; 168(1):188-90. PubMed ID: 8257487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.
    St Georgiev V
    Med Res Rev; 1993 Sep; 13(5):529-68. PubMed ID: 8412407
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole.
    Price DA; Hollings NP; Janes SM; Main J; Coker RJ
    J Antimicrob Chemother; 1994 Aug; 34(2):303. PubMed ID: 7814298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.